Premium
A case of disseminated Mycobacterium bovis 2 years post‐intravesicular Bacillus Calmette–Guérin therapy for superficial urinary bladder cancer
Author(s) -
Robinson Alexander R. L.,
Radhakrishnan Rajeswari,
Horvath Robert,
Pandey Sushil
Publication year - 2017
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.13475
Subject(s) - medicine , mycobacterium bovis , bladder cancer , bacillus (shape) , bcg vaccine , urinary bladder , mycobacterium , urinary system , cancer , surgery , pathology , microbiology and biotechnology , tuberculosis , mycobacterium tuberculosis , biology
Disseminated Mycobacterium bovis is an uncommon side‐effect of intravesical Bacillus Calmette–Guérin ( BCG ) therapy that may be mediated through Mycobacteraemia. This case report, of a 77‐year‐old man with a history of intravesical BCG therapy and recent cardiac surgery, highlights the need for patients with similar features on history, presenting with generalised symptoms, to have mycobacterial cultures included in their workup.